• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds

Is There Value to the Use of Corticosteroids in Women with Short Cervix Who Are Asymptomatic?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • ACOG recommends antenatal corticosteroids between 24 and 34 weeks for women “at risk” for delivery within 7 days
  • While there is demonstrated benefit to antenatal corticosteroids, there are also potential harms, especially with multiple doses
  • A short cervix is a risk factor for preterm birth
  • Richards et al. (Amer J Perinatol, 2017) sought to evaluate the number of asymptomatic women with a short cervix who would benefit from antenatal corticosteroids based on the recommended treatment window
  • The authors also assessed whether waiting until patients were asymptomatic would allow for a full course prior to delivery

METHODS:

  • Retrospective chart review
  • Inclusion: Patients with short cervix between 23w0d and 33w6d who had a cervical length < 2.5 cm and were asymptomatic
  • Antenatal corticosteroids were administered at the discretion of the MFM

RESULTS:

  • 367 asymptomatic patients were included, with only two delivering within 7 days from the time a short cervix was identified
  • 2/3 of asymptomatic patients with a short cervix received antenatal corticosteroids based on additional risk factors such as prior history of preterm birth
  • Number needed to treat (NNT): 184 asymptomatic patients would need to be treated at the time a short cervix is identified for one patient to benefit
  • If a more stringent cervical length criteria was used, e.g., 2.0 cm cutoff, NNT would be 130
  • 6% of patients delivered within 48 hours after onset of symptoms with a median time to delivery of 4 hours
    • Waiting for symptoms would not have provided benefit due to short interval until delivery

CONCLUSION:

  • The authors conclude that unless future studies demonstrate neonatal benefit of administration, antenatal corticosteroids should not be given to women solely because of shortened cervix

Learn More – Primary Sources:

Anticipatory Corticosteroid Administration to Asymptomatic Women with a Short Cervix

image_pdfFavoriteLoadingFavorite

< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Do Progestogens Prevent Preterm Birth in Symptomatic Pregnancies with a Short Cervix?
Meta-analysis: Cerclage for Short Cervix but Without History of Preterm Birth 
Short Cervix and Risk for Preterm Birth: Do Pessaries Work? 

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Download Your ObG App
HERE!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site